This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Safety and Pharmacokinetics of MK-7680 in Particip...
Clinical trial

Safety and Pharmacokinetics of MK-7680 in Participants With Hepatitis C (MK-7680-003)

Read time: 1 mins
Last updated:16th Oct 2014

This is a two-part dose-finding trial of MK-7680 in participants with Hepatitis C Virus (HCV) infection of genotype (GT)1 (Part I) and GT3 (Part 2). The primary hypothesis is that daily administration of a safe and well tolerated dose of MK-7680 will produce a decrease in HCV viral load.

Category Value
Study start date 2014-10-16

View full details